Kamboh MI. Genomics and Functional Genomics of Alzheimer’s Disease. Neurotherapeutics. 2021. https://doi.org/10.1007/S13311-021-01152-0
Guzman-Martinez L, Maccioni RB, Farías GA, Fuentes P, Navarrete LP. Biomarkers for Alzheimer´s disease. Curr Alzheimer Res. 2019;16:518–28.
Naj AC, Schellenberg GD, Alzheimer’s Disease Genetics Consortium (ADGC). Genomic variants, genes, and pathways of Alzheimer’s disease: An overview. Am J Med Genet Part B Neuropsychiatr Genet. 2017;174:5–26.
Giau V, Van Bagyinszky E, Yang YS, Youn YC, An SSA, Kim SY. Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing. Sci Rep. 2019;9.
-100x70.jpg "Understanding What the FDA’s Accelerated Approval of Aduhelm Means for the Alzheimer’s Community")
